No Half Measures: How Medical Affairs Can Maximize and Measure Value
Published: | Updated:
Education and knowledge transfer must be prioritized for industry to see sizable improvement in medical affairs.
Ailsa Budden
Advertisement
Senior Director, Global Medical Education—Oncology, Eli Lilly
Articles by Ailsa Budden
Advertisement
Latest Updated Articles
No Half Measures: How Medical Affairs Can Maximize and Measure ValuePublished: March 25th 2022 | Updated: April 11th 2022
Advertisement
Advertisement
Trending on PharmExec
1
The Influence of Trump Rx in Pharmacy Benefit Managers, Retail Pharmacies, and Digital Health Platforms
2
Leading in the Psychedelic Space: Q&A with Tarek Rabah
3
Bringing HIV Prevention DTC: Q&A with Ashley Gildea
4
Boehringer Ingelheim Acquires Exclusive License from Sitryx Therapeutics for Preclinical Small Molecule Program
5